Patents by Inventor Yinsuo LU

Yinsuo LU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BENZIMIDAZOLE DERIVATIVE AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF
    Publication number: 20240246959
    Abstract: Disclosed are a compound of formula (I), a preparation method therefor, and a medical application thereof. In particular, provided are the compound of formula (I) or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof. These compounds are agonists of a glucagon-like peptide-1 receptor (GLP-1R). The present invention also relates to a pharmaceutical composition containing these compounds and use of the compound in a drug for treating diseases such as diabetes.
    Type: Application
    Filed: November 26, 2021
    Publication date: July 25, 2024
    Applicant: Shenzhen Salubris Pharmaceuticals Co., Ltd.
    Inventors: Junjun WU, Yinsuo LU, Jianli WU, Ying XIAO, Wei XING
  • Terpyridinedione compound or salt thereof, and preparation method and application thereof
    Publication number: 20240166627
    Abstract: This application belongs to the technical field of chemical drugs, and relates to a compound shown in a general formula (I), or racemate thereof, or an isomer thereof, or a pharmaceutically acceptable salt thereof, which, as a p38/MK2 inhibitor, may inhibit the generation of cytokines TNF? and is used for treating diseases such as arthritis.
    Type: Application
    Filed: April 27, 2023
    Publication date: May 23, 2024
    Inventors: Junjun WU, Yinsuo LU, Ying XIAO, Zexin HONG, Liulin WANG, Zenan SONG
  • FXIA INHIBITORS AND PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF
    Publication number: 20230027295
    Abstract: Provided in the present invention is a series of selective Factor XIa (FXIa) inhibitors, relating to the technical field of chemical drugs. The present invention also relates to pharmaceutical compositions containing said compounds and a use of said compounds in drugs for the treatment of diseases such as thromboembolism.
    Type: Application
    Filed: September 24, 2020
    Publication date: January 26, 2023
    Applicant: Shenzhen Salubris Pharmaceuticals Co., Ltd.
    Inventors: Junjun WU, Yinsuo LU, Ying XIAO, Zexin HONG, Jianli WU, Wei XING